48TWENTYFOURSEVENBIOPHARMA Issue 2 / June 2025 AGC PHARMA CHEMICALS The pharmaceutical industry is a dynamic and rapidly evolving sector that requires an efficient and flexible supply chain to ensure the timely and reliable delivery of products. Within this industry, Contract Development and Manufacturing Organizations (CDMOs) play a crucial role in the development and production of small molecules, serving as essential partners to pharmaceutical companies. However, the challenges faced by CDMOs in managing the supply chain for small molecules are often underestimated. In recent years, the pharmaceutical industry has witnessed a significant shift towards building a more resilient and flexible supply chain that can adapt to the changing dynamics of the world. This evolution has been largely driven by the uptake of advanced data and analytical technologies, leveraging cloud-based solutions. These technologies are proving to be pivotal in delivering the solutions that the industry needs to prepare for the future. Supply chain strategy and growth In the area of CDMOs, supply chain strategy is intrinsically tied to growth strategy. The ultimate goal is to be a reliable and transparent supply chain partner for the pharmaceutical industry, thereby facilitating innovation and improving patient outcomes. CDMOs like AGC Pharma Chemicals define a robust supply chain able to mitigate risks in order to deliver APIs and intermediates on time that meet quality standards. The importance of high-performance supply chain partners The CDMO leadership depends on supply chain partners. Customers, including pharmaceutical and biotechnology companies, depend on APIs being delivered on time with the required quality. This dependence is particularly evident in a world that, despite geopolitical conflicts, relies on the continuous flow of pharmaceutical products to meet healthcare needs. Therefore, there is a growing emphasis on engaging manufacturing partners with highlyintegrated, sustainable and transparent supply chain operations. Leveraging advanced data and analytics One key aspect of this shift is the utilisation of advanced data and analytics. Companies are now
RkJQdWJsaXNoZXIy MjY2OTA4MA==